Meyer Andrew Hollman
SEC insider (Form 3/4/5 filer). CIK 0001864159. Chief Business Officer at Janux Therapeutics, Inc. (JANX). 31 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.
Companies Meyer Andrew Hollman has filed insider reports for
- Janux Therapeutics, Inc. (JANX): Officer, Chief Business Officer
Meyer Andrew Hollman
CIK: 0001864159
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Janux Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Jan 2, 2026JANX
Janux Therapeutics, Inc.
SaleDirect1.9K shares at avg. $13.73$26K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
SaleDirect2.7K shares at avg. $32.85$89K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
SaleDirect633 shares at avg. $33.52$21K - Dec 1, 2025JANX
Janux Therapeutics, Inc.
ExerciseDirect3.3K shares at avg. $10.59$35K - Nov 14, 2025JANX
Janux Therapeutics, Inc.
ExerciseDirect3.3K shares at avg. $10.59$35K - Nov 14, 2025JANX
Janux Therapeutics, Inc.
SaleDirect3.3K shares at avg. $30.00$100K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
ExerciseDirect6.7K shares at avg. $10.59$71K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
SaleDirect16.7K shares at avg. $30.06$501K - Oct 28, 2025JANX
Janux Therapeutics, Inc.
ExerciseDirect10K shares at avg. $4.21$42K - May 1, 2025JANX
Janux Therapeutics, Inc.
ExerciseDirect3.3K shares at avg. $4.21$14K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | JANX Janux Therapeutics, Inc. | Sale | 1,879 | $13.73 | $25,799 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Sale | 2,700 | $32.85 | $88,708 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Sale | 633 | $33.52 | $21,221 | Direct |
| Dec 1, 2025 | JANX Janux Therapeutics, Inc. | Exercise | 3,333 | $10.59 | $35,296 | Direct |
| Nov 14, 2025 | JANX Janux Therapeutics, Inc. | Exercise | 3,333 | $10.59 | $35,296 | Direct |
| Nov 14, 2025 | JANX Janux Therapeutics, Inc. | Sale | 3,333 | $30.00 | $99,990 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Exercise | 6,666 | $10.59 | $70,593 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Sale | 16,665 | $30.06 | $500,987 | Direct |
| Oct 28, 2025 | JANX Janux Therapeutics, Inc. | Exercise | 9,999 | $4.21 | $42,096 | Direct |
| May 1, 2025 | JANX Janux Therapeutics, Inc. | Exercise | 3,333 | $4.21 | $14,032 | Direct |
1-10 of 31 transactions